Implementing an adapted COVID-19 vaccine strategy for high-risk and older adults in Costa Rica is expected to be cost-saving, with broader age group eligibility yielding even greater benefits.
Baldi-Castro et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: